Monday, October 27, 2014

Merck Revenue Sags 4% in Third Quarter by KATIE THOMAS



By KATIE THOMAS


The pharmaceutical company’s earnings beat expectations, however, helped by sales of the diabetes drug Januvia and revenue in emerging markets.


Published: October 28, 2014 at 12:00AM


from NYT Business Day http://ift.tt/1tZpOy0






from WordPress http://ift.tt/1t9G103

via Hadi Aboukhater

No comments:

Post a Comment